Treatment with grazoprevir/elbasvir for renal transplant recipients with chronic hepatitis C virus infection and impaired allograft function | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Treatment with grazoprevir/elbasvir for renal transplant recipients with chronic hepatitis C virus infection and impaired allograft function

Eisenberger U, Friebus-Kardash J, Guberina H, et al. Treatment with grazoprevir/elbasvir for renal transplant recipients with chronic hepatitis C virus infection and impaired allograft function. Transplant Direct. 2019;5(1):e419.

Publication Type:

Journal Article

Authors:

Eisenberger, U; Friebus-Kardash, J; Guberina, H; et, al

Source:

Transplant Direct, Volume 5, Issue 1, p.e419 (2019)

Cited On:

Kidney Transplant Patients

Export Citation:

RIS Format

Top